Tolllike receptor 4 (TLR4) polymorphisms in Tunisian patients with Crohn's disease: Genotype-phenotype correlation

BMC Gastroenterology

Volumn 9, Issue , 2009, Pages

  Zouiten Mekki, Lilia ^a,b   Kharrat, Maher ^b   Karoui, Sami ^a   Serghimi, Mariem ^a   Fekih, Monia ^a   Matri, Samira ^a   Kallel, Lamia ^a   Boubaker, Jalel ^a   Filali, Azza ^a   Chaabouni, Habiba ^b  

^a LA RABTA HOSPITAL   (Tunisia)

^b UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; GLYCINE; ISOLEUCINE; THREONINE; TOLL LIKE RECEPTOR 4; TLR4 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CROHN DISEASE; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; THERAPY DELAY; TUNISIA; CASE CONTROL STUDY; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CASE-CONTROL STUDIES; CROHN DISEASE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; TOLL-LIKE RECEPTOR 4; TUNISIA;

EID: 69949175996     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-9-62     Document Type: Article

References (43)

1. Cantor MJ Nickerson P Bernstein CN The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease Am J Gastroenterol 2005, 100(5):1134-42. 10.1111/j.1572-0241.2005.40979.x 15842590
2. Ahmad T Tamboli PC Jewell D Clinical relevance of advances in Genetics and pharmacogenetics of IBD Gastroenterology 2004, 126:1533-1549. 10.1053/j.gastro.2004.01.061 15168365
3. Mathew CG Lewis CM Genetics of inflammatory bowel disease: Progress and prospects Hum Mol Genet 2004, 13:R161-R168. 10.1093/hmg/ddh079 14764625
4. Newmann B Siminovitch KA Recent advances in the genetics of inflammatory bowel disease Curr Opin Gastroenterol 2005, 21(4):401-7. 15930978
5. Ogura Y Bonen DK Inohra N Nicolae DL Chen FF Ramos R Britton H Moran T Karaliuskas R Duerr RH Achkar JP Brant SR Bayless TM Kirshner BS Hanauer SB Nunez G Cho JH A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease Nature 2001, 411:603-606. 10.1038/ 35079114 11385577
6. Hugot JP Chamaillard M Wouali H Lesage S Cezard JP Belaiche J Almer S Tysk C O'Morain CA Gassul M Binder V Finkel Y Cortot A Modigliani R Laurent Puig P Gower Rousseau C Macry J Colombel JF Sahbatou M Thomas G Association of NOD 2 leucine repeat variants with susceptibility to Crohn's disease Nature 2001, 411:599-603. 10.1038/35079107 11385576
7. Hampe J Cuthbert A Croucher PJ Mirza MM Mascheretti S Fisher S Frenzel H King K Hasselmeyer A MacPherson AJ Bridger S Van Deventer S Forbes A Nikolaus S Lennard Jones JE Foelsch UR Krawczak M Lewis C Schreiber S Mathew CG Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations Lancet 2001, 357:1925-1928. 10.1016/S0140-6736(00)05063-7 11425413
8. Bonen DK Ogura Y Nicolae DL Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan Gastroenterology 2003, 124:140-146. 10.1053/ gast.2003.50019 12512038
9. Inohara N Ogura Y Fontalba A Host recognition of bacterial muramyl dipeptide mediated through NOD2 Implications for Crohn's disease 2003, 278:5509-5512.
10. Girardin SE Boneca IG Viala J Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection J Biol Chem 2003, 278:8869-8872. 10.1074/jbc.C200651200 12527755
11. Fort MM Mozaffarian A Stover AG Correia Jda S Johnson Marsh S McLeod HL Crohn's disease: Ethnic variation in CARD15 genotypes Gut 2003, 52:770. 10.1136/gut.52.5.770
12. Zouiten-Mekki L Zouali H Boubaker J CARD15/NOD2 in Tunisian population with Crohn's disease Dig Dis Sci 2005, 50(1):130-135. 10.1007/ s10620-005-1290-0 15712650
13. Inoue N Tamura K Kinouchi Y Fukuda Y Takahashi S Ogura Y Inohara N Nunez G Kishi Y Koike Y Shimosegawa T Shimoyama T Hibi T Lack of common NOD2 variants in Japanese patients with Crohn's disease Gastroenterology 2002, 123:86-91. 10.1053/gast.2002.34155 12105836
14. Yamazaki K Takazoe M Tanaka T Kazumori T Nakamura Y Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease J Hum Genet 2002, 47:469-472. 10.1007/s100380200067 12202985
15. Leong RW Armuzzi A Ahmad T Wong ML Tse P Jewell DP Sung JJ NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population Aliment Pharmacol Ther 2003, 17:1465-1470. 10.1046/j.1365-2036.2003.01607.x 12823148
16. Croucher PJ Mascheretti S Hampe J et al Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations Eur J Hum Genet 2003, 11:6-16. 10.1038/ sj.ejhg.5200897 12529700
17. Riis LB Wolters F Solberg C Regional differences in the prevalence of single nucleotide polymorphisms in CARD15/NOD2 but not in toll-like receptor 4 (TLR4) Asp299Gly polymorphism in patients with inflammatory bowel disease (IBD) across Europe: Results from the EC-IBD study group Gastroenterology 2004, 126(Suppl S):M1539.
18. Takeda K Kaisho T Akira S Toll-like receptors Annu Rev Immunol 2003, 21:335-376. 10.1146/annurev.immunol.21.120601.141126 12524386
19. Hornef MW Normark BH Vandewalle A Normark S Intracellular recognition of lipopolysaccharide by toll-like receptor 4 in intestinal epithelial cells J Exp Med 2003, 198:1225-1235. 10.1084/jem.20022194 2194240 14568981
20. Cario E Podosky DK Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease Infect Immun 2000, 68:7010-7017. 10.1128/ IAI.68.12.7010-7017.2000 97811 11083826
21. Arbour NC Lorenz E Schutte BC TLR4 mutations are associated with endotoxin hyporesponsiveness in humans Nat Genet 2000, 25:187-191. 10.1038/76048 10835634
22. Schmitt C Humeny A Becker CM Brune K Pahl A Polymorphisms of TLR4: Rapid genotyping and reduced response to lipopolysaccharide of TLR4 mutant alleles Clin Chem 2002, 48:1661-1667. 12324481
23. Erridge C Stewart J Poxton IR Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations in the Toll-like receptor 4 gene show no deficit in lipopolysaccharide signaling J Exp Med 2003, 197:1787-1791. 10.1084/ jem.20022078 2193949 12796470
24. Torok HP Glas J Tonenchi L Mussack T Folwaczny C Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the toll-like receptor 4 gene with ulcerative colitis Clinical immunology 2004, 112:85-91. 10.1016/ j.clim.2004.03.002 15207785
25. Gazouli M Mantzaris G Kotsinas A Zacharatos P Papalambros E Archimandritis E Ikonomopoulos J Gorgoulis VG Association between polymorphisms in the Toll-like receptor 4, CD14 and CARD15/NOD2 and inflammatory bowel disease in the Greek population W J Gastroenterol 2005, 11:681-685.
26. Franchimont D Vermeir S El Housni H Pierik M Van Steen K Gustot T Quertinmont E Abramowicz M Van Gossum A Devière J Rutgeerts P Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp 299Gly polymorphism is associated with Crohn's disease and ulcerative colitis Gut 2004, 53:987-992. 10.1136/ gut.2003.030205 1774122 15194649
27. Kornbluth A Salomon P Sachar DB Crohn's disease Gastrointestinal disease: Pathophysiologie/diagnosis/management Philadelphia: Sanders Sleisenger MH, Fordtran JS 5 1993, 2:1270-302.
28. Gasche C Scholmerich J Brynskov J A simple classification of crohn's disease report of the working party for the world congressess of gastroenterology Vienna 1998 Inflamm Bowel Dis 1998, 6:8-15.
29. Zouiten-Mekki L Karoui S Kharrat M et al Crohn's disease and polymorphism of heat Shock Protein gene HSP70-2 in Tunisian population Eur J Gastroenterol Hepatol 2007, 19(3):225-228. 10.1097/ 01.meg.0000252625.65549.29 17301649
30. Agnese DM Calvano JE Hahm SJ Coyle SM Corbett SA Calvano SE Lowry SF Human Toll-Like Receptor 4 Mutations but Not CD14 Polymorphisms Are Associated with an Increased Risk of Gram-Negative Infections J Inf Diseases 2002, 186:1522-5. 10.1086/344893
31. Rakoff-Nahoum S Paglino J Eslami-Varzaneh F et al Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis Cell 2004, 118:229-41. 10.1016/j.cell.2004.07.002 15260992
32. Okayama N Fujimura K Suehiro Y et al Simple genotype analysis of the Asp299Gly polymorphism of the toll-like receptor-4 gene that is associated with lipopolysaccharide hyporesponsiveness J Clin Lab Anal 2002, 16:56-8. 10.1002/jcla.2075 11835533
33. Lakatos PL Lakatos L Szalay F Willheim-Polli C Österreicher C et al Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn's disease: Phenotype-genotype correlations World J Gastroenterol 2005, 11:1489-1495. 15770725
34. Leshinsky-silver E Karban A Buzhakor E Fridlander M Yakir B Eliaakim R Reif S Shaul R Boaz M Lev D Levine A Is age of onset of Crohn's disease governed by mutations in NOD2/caspase recruitment domains 15 and Toll-like receptor 4? Evaluation of a pediatric cohort Pediatr Res 2005, 58:499-504. 10.1203/01.PDR.0000175640.75468.D6 16148063
35. Ouburg S Mallant-Hent R Crusius JBA van Bodegraven AA Mulder CJJ Linskens R Pena AS Morre SA The toll-like receptor 4 (TLR4) Asp299Gly polymorphism is associated with colonic localisation of Crohn's disease without a major role for the Saccharomyces cerevisiae mannan-LBP-CD14-TLR4 pathway Gut 2005, 54:439-440. 1774408 15710998
36. Debler J Schiemann U Seybold U et al Heat-shock protein HSP70-2 genotypes in patients with Crohn's disease: A more severe clinical course with intestinal complications in presence of the PstI-polymorphism Eur J Med Res 2003, 27:120-4.
37. Esaki M Furuse M Matsumoto T et al Polymorphism of heat shock protein gene HSP70-2 in Crohn disease: Possible genetic marker for two forms of Crohn disease Scand J Gastroenterol 1999, 34:703-707. 10.1080/ 003655299750025912 10466882
38. Brand S Staudinger T Schnitzler F Pfennig S Hofbauer K Dambacher J Seiderer J Tillack C Konrad A Crispin A Goke B Lohse P Ochsenkuhn T The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's disease Inflamm Bowel Dis 2005, 11:645-652. 10.1097/ 01.MIB.0000168372.94907.d2 15973118
39. Arnott IDR Nimmo ER Drummond HE et al NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: Evidence for genetic heterogeneity within Europe? Genes Immun 2004, 5:417-25. 10.1038/ sj.gene.6364111 15190267
40. Nimmo ER Arnott IDR Drummond HE et al Mutations of toll-like receptor 4 and CD 14 genes are not associated with susceptibility or disease behaviour in inflammatory bowel disease Gastroenterology 2003, 124(Suppl 1):A373.
41. Oostenbrug LE De Jong D Drenth JPH et al Lack of association between toll-like receptor 4 haplotype and Asp299Gly polymorphism and susceptibility for inflammatory bowel disease Gastroenterology 2003, 124(Suppl 1):A372. 10.1016/S0016-5085(03)81884-X
42. Noble C Nimmo E Gaya D Russell RK Satsangi J Novel susceptibility genes in inflammatory bowel disease World J Gastroenterol 2006, 12(13):1991-1999. 16610046
43. Arnott ID Nimmo ER Drummond HE Fennell J Smith BR Oostenbrug LE Drenth JP de Jong D Nolte IM Oosterom E van Dullemen HM Linde van der K te Meerman GJ Steege van der G Kleibeuker JH Jansen PL Association between Toll like receptor 4 and inflammatory bowel disease Inflamm Bowel Dis 2005, 11:567-575. 10.1097/01.MIB.0000161305.81198.0f 15905704